When Jimmy Carter was diagnosed with end-stage metastatic melanoma in 2015, he began taking a drug developed in part using 3D molecular data. Insights like these into drug discovery and other fields of scientific research are possible using the 140,000-plus 3D molecular structures made freely available in the RCSB Protein Data Bank at Rutgers University-New Brunswick.
As graduation celebrations turn to summer internships and, hopefully, new jobs, Missourians were greeted with a report that should ring the alarm and cause us all to rethink education. The Missouri Chamber of Commerce highlighted that by 2030, Missouri will face a shortage of 200,000 qualified workers. This report mirrors other findings that point to deficits within the science-, technology-, engineering-, and math-based (STEM) talent pipelines.
Cardiac patients are one step closer to obtaining a medical device that can alert them to a potential Acute Coronary Syndrome (ACS) event, including a heart attack, whether they experience symptoms or not, following recent U.S. Food and Drug Administration (FDA) approval of the AngelMed Guardian® System. Considered Monmouth County-based Angel Medical Systems’ flagship product, the AngelMed Guardian System is the world’s first implantable cardiac monitor and patient alerting system for ACS.
The NYU Stern School of Business hosted the finals of its annual $300K Entrepreneurs Challenge in which venture teams pitched to a panel of judges tasked with deciding the winner of each of the Challenge’s three venture competitions. In addition to the Challenge, the winner of Stern’s W. R. Berkley Innovation Labs Mobile App Contest was announced, who will have their app fully developed—awarding them a prize valued at $75,000.
Vince Forlenza, President and CEO of BD, is the keynote speaker. Leading innovation throughout the enterprise in today’s environment is incredibly challenging. This year’s Summit will include a keynote lecture by one of the top CEOs in the healthcare industry. A CEO panel will follow and offer additional insights and perspectives on managing combined organizations. Discussion groups will follow to further share best practices among attendees.
According to RIO-NJ, Senator Paul Sarlo (D-Wood-Ridge) “discussed the new Hackensack Meridian Medical School at Seton Hall University, and how it is part of a greater economic revitalization for Clifton and Nutley. ‘When Hoffmann-La Roche pulled out, it was a huge hole in our economy. And not just a huge hole in the economy, but this parcel of land – leaving it vacant and turning it into strip malls just didn’t feel right. Today, we are able to turn this into a place where we are going to educate the next generation of medical leaders.
People in the U.S. strongly support spending federal money to invest in scientific and medical research. A new Pew Research Center survey finds that roughly 80 percent of adults in the U.S. say it’s worthwhile for the government to invest in medical, engineering and technology, and basic science research. That held true for the majority of both Republicans and Democrats, but support was higher among Democrats – 92 percent of liberal Democrats said government investments in basic science pay off in the long run, compared to 61 percent of conservative Republicans.